Back to results
US 6,630,496 B1Granted
Inhibitors of phospholipase enzymes
AssigneeGenetics Institute, Inc.
InventorsJasbir S. Seehra, Neelu Kaila, John C. McKew, Jean E. Bemis, YiBin Xiang, Lihren Chen
Life of this patent
Estimating the term…
Abstract
This invention provides substituted indole and indoline compounds useful in inhibiting phospholipase activity, particularly including cytosolic phospholipase A2 (cPLA2) activity, as well as pharmaceutical compositions containing the compounds and methods of using them to treat various maladies, including pain and inflammatory conditions.
Claims18
A compound of the formula:
- wherein:
- R1 and R1′ are independently selected from the group consisting of H, C1-C6 alkyl, —Z—C1-C6 alkyl, phenyl, —(CH2)n—Z—(CH2)n-phenyl, benzyl, —(CH2)n—Z—(CH2)n-benzyl, naphthyl, —(CH2)n—Z—(CH2)n-napthyl, pyrimidinyl, and —(CH2)n—Z—(CH2)n-pyrimidinyl, wherein the alkyl, phenyl, benzyl, napthyl and pyrimidinyl groups may be optionally substituted by from 1 to 3 substituents selected from halogen, C1-C6 alkyl, C1-C6 alkoxy, —NO2, —NH2, —CN, —CF3, and —OH;
- Z is O or S;
- n is an integer from 0 to 3;
- R2 is selected from the group consisting of H, halogen, —CF3, —OH, —C1-C10 alkyl, C1—C10 alkoxy, —CHO, —CN, —NO2, —NH2, —NH—C1-C6 alkyl, —N(C1-C6 alkyl)2, —NH—SO2—C1-C6 alkyl, and —SO2-C1-C6 alkyl;
- R3 is selected from the group consisting of H, halogen, —CF3, —OH, C1-C10 alkoxy, —CHO, —CN, —NO2, —NH2, —NH—C1-C6 alkyl, —N(C1-C6 alkyl)2, —NH—SO2—C1-C6 alkyl, and —SO2—C1-C6 alkyl;
- n in each appearance is independently an integer selected from 0-3;
- R4 is
- R12 is selected from the group consisting of H, —CF3, C1-C6 alkyl, —(CH2)n—C3-C6 cycloalkyl, phenyl, and benzyl, the cycloalkyl, phenyl or benzyl groups being optionally substituted by from 1 to 3 groups selected from the group consisting of halogen, —CF3, —OH, —COOH, —(CH2)n—COOH, —(CH2)n—C(O)—COOH, —C1-C6 alkyl, —O—C1-C6 alkyl, —NH(C1-C6 alkyl), and —N(C1-C6 alkyl)2;
- R5 is selected from the group consisting of 4-{[3,5-bis(trifluoromethyl)phenoxy]-methyl}benzyl, 3-[3,5-bis(trifluoromethyl)phenoxy]propyl, 2,4-bis(trifluoromethyl)benzyl, 4-chlorobenzyl, 2-naphthylmethyl, 4-benzylbenzyl, and 3-[3,5-bis(trifluoromethyl)phenoxy]-propyl;
- provided that R1, R1′, R2 and R3 are not all H, or a pharmaceutically acceptable salt thereof.
8 more elements
Dependencies are inferred from the claim text.